Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jeffrey Field

Showing results (51-60 of 55) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 55 results.
The Journal of Cell Biology|May 19, 2004
c-Abl phosphorylates Dok1 to promote filopodia during cell spreadingPamela J Woodring, Jill Meisenhelder, Sam A Johnson, et al.
American Journal of Cancer Research|May 5, 2017
Comprehensive pharmacological profiling of neurofibromatosis cell linesJianman Guo, Michael R Grovola, Hong Xie, et al.
Oncogene|July 25, 2021
Targeting mTOR signaling overcomes acquired resistance to combined BRAF and MEK inhibition in BRAF-mutant melanomaBeike Wang, Wei Zhang, Gao Zhang, et al.
Nature|September 28, 2017
PAK signalling drives acquired drug resistance to MAPK inhibitors in BRAF-mutant melanomasHezhe Lu, Shujing Liu, Gao Zhang, et al.
Nature|December 12, 2018
Author Correction: PAK signalling drives acquired drug resistance to MAPK inhibitors in BRAF-mutant melanomasHezhe Lu, Shujing Liu, Gao Zhang, et al.
Pageof 6

Showing results (51-60 of 55) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 55 results.
The Journal of Cell Biology|May 19, 2004
c-Abl phosphorylates Dok1 to promote filopodia during cell spreadingPamela J Woodring, Jill Meisenhelder, Sam A Johnson, et al.
American Journal of Cancer Research|May 5, 2017
Comprehensive pharmacological profiling of neurofibromatosis cell linesJianman Guo, Michael R Grovola, Hong Xie, et al.
Oncogene|July 25, 2021
Targeting mTOR signaling overcomes acquired resistance to combined BRAF and MEK inhibition in BRAF-mutant melanomaBeike Wang, Wei Zhang, Gao Zhang, et al.
Nature|September 28, 2017
PAK signalling drives acquired drug resistance to MAPK inhibitors in BRAF-mutant melanomasHezhe Lu, Shujing Liu, Gao Zhang, et al.
Nature|December 12, 2018
Author Correction: PAK signalling drives acquired drug resistance to MAPK inhibitors in BRAF-mutant melanomasHezhe Lu, Shujing Liu, Gao Zhang, et al.
Pageof 6